The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Immunotherapy
- Lung Cancer
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04286841
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon